Patients with moderate or severe atopic dermatitis require a structured approach that goes beyond basic skin care. This protocol provides evidence-based guidance for this specific level of disease severity.
The patient has moderate atopic dermatitis or severe atopic dermatitis. Standard topical therapy is part of the foundation, and the protocol addresses what to add at this level of severity.
The protocol layers an adjunctive bathing intervention on top of topical therapy for patients at this severity level. The complete regimen, including the specific intervention, its integration with other measures, and decision points, is in the full protocol.
Dosing, frequency, sequencing, and the complete clinical algorithm remain in the structured protocol — access it below.
The target outcome is 50% improvement in atopic dermatitis severity. Meaningful response is expected to be detectable within 4 weeks of starting the adjunctive intervention.
DOI: 10.1016/j.anai.2023.11.009
In patients with moderate-severe atopic dermatitis, the JTF panel suggests, in addition to topical therapy, dilute bleach baths over usual (no dilute bleach-based) baths (conditional recommendation, low-certainty evidence).
The linked systematic review and meta-analysis synthesizing 10 RCTs revealed that the probability to improve AD severity by 50% with adjunctive dilute bleach baths was 32% vs 22% in the control group (moderate certainty).
Patients using dilute bleach baths were likely to see effects in AD severity within 4 weeks of treatment.
View source ↗